TP53 and ovarian carcinoma: In general, the present study suggested that abnormal activation of CDK1 was implicated in the proliferation and apoptosis regulation of ovarian cancer cells, which might due to the aberrant regulations of the upstream Chk1-CDC25C and P53-P21WAF1 signaling pathway.